Partnering– パートナリング –

NBHL is actively promoting co-development and technology alliances
with many companies and research institutions
to infuse new value into GPCR drug discovery.


Collaboration Opportunities – 共同開発について

NBHL is proud to introduce our promising pipelines to pharmaceutical companies. We are seeking partners particularly for the clinical development and commercialization of the following diseases and pipelines.


Technology Alliance – 技術提携について

We are looking for pharmaceutical companies and biotech companies globally, which have interest in using “MoGRAA® Discovery Engine”, our proprietary drug discovery platform specialized for GPCR-targeted antibodies as part of a therapeutic antibody discovery program.


Please contact us for partnership inquiries